Connect Biopharma (NASDAQ: CNTB) net income
Connect Biopharma reported a net loss of $55.5m for fiscal 2025; in fiscal 2024 it reported a net loss of $15.6m. Earnings per share were −$1.00.
Connect Biopharma's best year of the last 3 was fiscal 2024. It reported a loss in 3 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$55.5m | — | −86,687.5% | −$1.00 |
| 2024 | −$15.6m | — | −60.0% | −$0.28 |
| 2023 | −$62.1m | — | — | −$1.13 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Connect Biopharma net income compared with its sector
By net income for its latest fiscal year, Connect Biopharma ranks 266th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Connect Biopharma, −86,687.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 264th | CeriBell | −$53.4m | −60.0% |
| 265th | Achieve Life Sciences | −$54.6m | — |
| 266th | Connect Biopharma | −$55.5m | −86,687.5% |
| 267th | Azenta | −$55.8m | −9.4% |
| 268th | Immuneering | −$56.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Connect Biopharma
- How much did Connect Biopharma earn in fiscal 2025?
- Connect Biopharma reported a net loss of $55.5m for fiscal 2025. In fiscal 2024 it reported a net loss of $15.6m.
- What are the earnings per share of Connect Biopharma?
- They were −$1.00 in fiscal 2025, compared with −$0.28 in fiscal 2024.
- Where does Connect Biopharma rank in its sector by net income?
- It ranks 266th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Connect Biopharma come from?
- From the annual report (Form 10-K) that Connect Biopharma files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Connect Biopharma files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Connect Biopharma: the Connect Biopharma page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.